CR MEDICAL appoints Yu Changjiu as Chief Financial Officer, effective 20 August 2026

Bulletin Express

Aug 20

China Resources Medical Holdings Company Limited (CR MEDICAL) has named Yu Changjiu, 46, as its Chief Financial Officer, with the appointment taking effect on 20 August 2026.

Yu currently serves as CFO of China Resources Healthcare Group Limited, the intermediate controlling shareholder of CR MEDICAL. From April 2018 to July 2026, he held multiple senior posts within the Financial Management Center of China Resources Double-Crane Pharmaceutical Co., Ltd. (SSE: 600062), including General Manager roles in Business Finance Management, Finance Function Management, and the Financial Shared Service Center, as well as Vice General Manager and later General Manager of the overall center.

Yu’s prior experience also includes senior finance positions at Hunan Xiangzhong Pharmaceutical Co., Ltd., Beijing Scrianen Pharmaceutical Co., Ltd., and Beijing Double-Crane Pharmaceutical Business Co., Ltd. He holds a bachelor’s degree in economics from Inner Mongolia Finance and Economics College, a master’s degree in engineering from Beihang University, and carries the professional title of Senior Accountant.

The Board of Directors, chaired by Yu Hai, extended its formal welcome to the incoming CFO. As of the announcement date, CR MEDICAL’s Board comprises four Executive Directors, one Non-executive Director, and four Independent Non-executive Directors.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1144188577"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144188577\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144188577?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 19:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144188577","market":"us","top_or_hot":-1,"title":"CR MEDICAL appoints Yu Changjiu as Chief Financial Officer, effective 20 August 2026","media":"Bulletin Express","content":"<p>China Resources Medical Holdings Company Limited (CR MEDICAL) has named Yu Changjiu, 46, as its Chief Financial Officer, with the appointment taking effect on 20 August 2026.</p>\n<p>Yu currently serves as CFO of China Resources Healthcare Group Limited, the intermediate controlling shareholder of CR MEDICAL. From April 2018 to July 2026, he held multiple senior posts within the Financial Management Center of China Resources Double-Crane Pharmaceutical Co., Ltd. (SSE: 600062), including General Manager roles in Business Finance Management, Finance Function Management, and the Financial Shared Service Center, as well as Vice General Manager and later General Manager of the overall center.</p>\n<p>Yu’s prior experience also includes senior finance positions at Hunan Xiangzhong Pharmaceutical Co., Ltd., Beijing Scrianen Pharmaceutical Co., Ltd., and Beijing Double-Crane Pharmaceutical Business Co., Ltd. He holds a bachelor’s degree in economics from Inner Mongolia Finance and Economics College, a master’s degree in engineering from Beihang University, and carries the professional title of Senior Accountant.</p>\n<p>The Board of Directors, chaired by Yu Hai, extended its formal welcome to the incoming CFO. As of the announcement date, CR MEDICAL’s Board comprises four Executive Directors, one Non-executive Director, and four Independent Non-executive Directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR MEDICAL appoints Yu Changjiu as Chief Financial Officer, effective 20 August 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR MEDICAL appoints Yu Changjiu as Chief Financial Officer, effective 20 August 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-20 19:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Medical Holdings Company Limited (CR MEDICAL) has named Yu Changjiu, 46, as its Chief Financial Officer, with the appointment taking effect on 20 August 2026.</p>\n<p>Yu currently serves as CFO of China Resources Healthcare Group Limited, the intermediate controlling shareholder of CR MEDICAL. From April 2018 to July 2026, he held multiple senior posts within the Financial Management Center of China Resources Double-Crane Pharmaceutical Co., Ltd. (SSE: 600062), including General Manager roles in Business Finance Management, Finance Function Management, and the Financial Shared Service Center, as well as Vice General Manager and later General Manager of the overall center.</p>\n<p>Yu’s prior experience also includes senior finance positions at Hunan Xiangzhong Pharmaceutical Co., Ltd., Beijing Scrianen Pharmaceutical Co., Ltd., and Beijing Double-Crane Pharmaceutical Business Co., Ltd. He holds a bachelor’s degree in economics from Inner Mongolia Finance and Economics College, a master’s degree in engineering from Beihang University, and carries the professional title of Senior Accountant.</p>\n<p>The Board of Directors, chaired by Yu Hai, extended its formal welcome to the incoming CFO. As of the announcement date, CR MEDICAL’s Board comprises four Executive Directors, one Non-executive Director, and four Independent Non-executive Directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01515","symbol_name":"华润医疗","start_time":0,"source_url":"","article_id":"1144188577","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144188577","pubTimestamp":1787225310,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Medical Holdings Company Limited (CR MEDICAL) has named Yu Changjiu, 46, as its Chief Financial Officer, with the appointment taking effect on 20 August 2026. Yu currently serves as...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01515":"华润医疗"},"translate_title":"华润医疗委任余昌久为首席财务官，自2026年8月20日起生效","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01515":1},"content_text":"China Resources Medical Holdings Company Limited (CR MEDICAL) has named Yu Changjiu, 46, as its Chief Financial Officer, with the appointment taking effect on 20 August 2026.\nYu currently serves as CFO of China Resources Healthcare Group Limited, the intermediate controlling shareholder of CR MEDICAL. From April 2018 to July 2026, he held multiple senior posts within the Financial Management Center of China Resources Double-Crane Pharmaceutical Co., Ltd. (SSE: 600062), including General Manager roles in Business Finance Management, Finance Function Management, and the Financial Shared Service Center, as well as Vice General Manager and later General Manager of the overall center.\nYu’s prior experience also includes senior finance positions at Hunan Xiangzhong Pharmaceutical Co., Ltd., Beijing Scrianen Pharmaceutical Co., Ltd., and Beijing Double-Crane Pharmaceutical Business Co., Ltd. He holds a bachelor’s degree in economics from Inner Mongolia Finance and Economics College, a master’s degree in engineering from Beihang University, and carries the professional title of Senior Accountant.\nThe Board of Directors, chaired by Yu Hai, extended its formal welcome to the incoming CFO. As of the announcement date, CR MEDICAL’s Board comprises four Executive Directors, one Non-executive Director, and four Independent Non-executive Directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}